I

I Sens Inc
KOSDAQ:099190

Watchlist Manager
I Sens Inc
KOSDAQ:099190
Watchlist
Price: 18 730 KRW -2.24% Market Closed
Market Cap: 517.6B KRW
Have any thoughts about
I Sens Inc?
Write Note

I Sens Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

I Sens Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
I
I Sens Inc
KOSDAQ:099190
Cash & Cash Equivalents
â‚©45.3B
CAGR 3-Years
-3%
CAGR 5-Years
6%
CAGR 10-Years
13%
Dentium Co Ltd
KRX:145720
Cash & Cash Equivalents
â‚©86.6B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
N/A
B
Biodyne Co Ltd
KOSDAQ:314930
Cash & Cash Equivalents
â‚©9.7B
CAGR 3-Years
48%
CAGR 5-Years
47%
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Cash & Cash Equivalents
â‚©52.9B
CAGR 3-Years
32%
CAGR 5-Years
115%
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Cash & Cash Equivalents
â‚©24.3B
CAGR 3-Years
-27%
CAGR 5-Years
2%
CAGR 10-Years
N/A
L
Lutronic Corp
KOSDAQ:085370
Cash & Cash Equivalents
â‚©50B
CAGR 3-Years
64%
CAGR 5-Years
69%
CAGR 10-Years
33%
No Stocks Found

I Sens Inc
Glance View

Market Cap
515.2B KRW
Industry
Health Care

i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-01-30. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The firm distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.

Intrinsic Value
21 099.3 KRW
Undervaluation 11%
Intrinsic Value
Price
I

See Also

What is I Sens Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
45.3B KRW

Based on the financial report for Jun 30, 2024, I Sens Inc's Cash & Cash Equivalents amounts to 45.3B KRW.

What is I Sens Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
13%

Over the last year, the Cash & Cash Equivalents growth was -15%. The average annual Cash & Cash Equivalents growth rates for I Sens Inc have been -3% over the past three years , 6% over the past five years , and 13% over the past ten years .

Back to Top